Acurx Pharmaceuticals, Inc. short interest in 2022
In 2022, Acurx Pharmaceuticals, Inc.'s disclosed short interest ran from 1.34% of shares outstanding on 14 Jan 2022 to 0.20% on 30 Dec 2022, a change of -1.14 percentage points. The year's high was 1.34% on 14 Jan 2022 and its low 0.19% on 31 Oct 2022, averaging 0.47% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.59 days on 14 Apr 2022. Full history: Acurx Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 1.34% (14 Jan 2022)
- End of year
- 0.20% (30 Dec 2022)
- Change
- -1.14 pp
- High
- 1.34% (14 Jan 2022)
- Low
- 0.19% (31 Oct 2022)
- Average
- 0.47%
- Highest days to cover
- 10.59 (14 Apr 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 1.34% | 5.73 | |
| 31 Jan 2022 | 0.95% | 1.43 | |
| 15 Feb 2022 | 0.91% | 6.34 | |
| 28 Feb 2022 | 0.42% | 1.86 | |
| 15 Mar 2022 | 0.46% | 2.56 | |
| 31 Mar 2022 | 1.09% | 3.37 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 0.85% | 10.59 | |
| 29 Apr 2022 | 0.34% | 3.56 | |
| 13 May 2022 | 0.48% | 2.21 | 10-Q filed, results (8-K) |
| 31 May 2022 | 0.47% | 6.20 | |
| 15 Jun 2022 | 0.55% | 1.69 | |
| 30 Jun 2022 | 0.39% | 3.64 | |
| 15 Jul 2022 | 0.22% | 1.86 | |
| 29 Jul 2022 | 0.41% | 5.24 | results (8-K) |
| 15 Aug 2022 | 0.32% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 0.21% | 1.11 | |
| 15 Sep 2022 | 0.23% | 1.00 | |
| 30 Sep 2022 | 0.34% | 1.45 | |
| 14 Oct 2022 | 0.26% | 2.54 | |
| 31 Oct 2022 | 0.19% | 1.14 | |
| 15 Nov 2022 | 0.20% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 0.20% | 1.26 | |
| 15 Dec 2022 | 0.25% | 1.14 | |
| 30 Dec 2022 | 0.20% | 1.00 |
See also: Acurx Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.